Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06725368
Title Carboplatin + Paclitaxel + Cetuximab (PCC) After Failure of Pembrolizumab +/- First-line Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (CARPACCIO)
Acronym CARPACCIO
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut de cancérologie Strasbourg Europe
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.